© 2020 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

Treatment News

liver, liver cancer
Predicting Liver Cancer in People Cured of Hepatitis C
Hepatitis C Medications
Forums: Support and discussion

Cotadutide Improves NASH Biomarkers in Overweight People With Diabetes

The experimental drug led to significant reduction in body weight but was accompanied by nausea and vomiting.

Abnormal Liver Tests Linked to Worse COVID-19 Outcomes

The prevalence of abnormal liver tests in people hospitalized with COVID-19 is higher than previously found.

Many People on Medicaid and Prisoners Still Lack Access to Hepatitis C Treatment

Some state Medicaid programs and prison systems still restrict treatment based on substance use or stage of liver disease.

Aldafermin Improves Fibrosis in People With NASH

A daily dose of the growth factor analogue administered over 24 weeks also aided in NASH resolution.

Substance Use Disorders Linked to Increased COVID-19 Risk

People with an opioid use disorder, in particular, had a tenfold higher risk of being diagnosed with COVID-19.

Testing People With Diabetes Can Detect More Liver Disease

Using a two-part testing plan could help identify those with advanced liver fibrosis among people with type 2 diabetes.

MUST read

Celebrities With Hepatitis
10 Tips to Protect Your Liver
Hep Stories: Get inspired
The 2017 Hepatitis C Treatment Pipeline
EASL 2017 Roundup: Continued Progress in Fighting Liver Disease
11 Signs of Liver Disease

HIV, Hep C Testing at Detox Centers Needs Strong Linkage-to-Care Effort

A recent study in Boston found that only 6% of people at detox centers who tested positive for either virus received follow-up medical care.

People With Alcohol-Related Liver Disease May Benefit from Fecal Microbial Transplant

Researchers suggest the process is safe and may help reduce alcohol cravings.

International Registries Shed More Light on Liver Disease and COVID-19

People with advanced liver cirrhosis are at greater risk for severe COVID-19 illness and death.

U.S. Is Not on Track to Hit the WHO’s Hep C Elimination Targets

Only three states are expected to meet the 2030 goal.
Hepatitis C virus

Do People With HIV Fare Worse After Being Cured of Hepatitis C?

Rates of liver complications were similar, but HIV-positive people had more non-liver cancers and non-liver-related deaths.

Hot topics

Hepatitis C: The Basics
Hepatitis B: The Basics
Hepatitis A: The Basics
NASH: The Basics

Multidisciplinary NAFLD Approach Improves Cardiovascular Risk

Researchers reported significant changes in liver, cardiovascular and diabetes markers.

Stivarga and Opdivo Provide Comparable Survival Benefits for People With Liver Cancer

Stivarga also improved survival in those with recurrent HCC after a liver transplant.
Hepatitis B virus

Switching From Viread to Vemlidy Keeps Hepatitis B Suppressed for Two Years

People who switched showed improvement in markers of kidney and bone health but also rise in lipid levels.

Liver Disease Is Leading Cause of Death Among People With NAFLD

Liver complications, heart disease and non-liver cancers also account for most deaths among people with hepatitis B or C.

Lenvima Plus Keytruda Shows Promise for Advanced Liver Cancer

Nearly half of patients treated with the combination saw their tumors shrink in an early study.
Advertisement
Newsfeed
Features

Hot topics

Forums: Support and discussion
Blogs: The community speaks
Hep Stories: Get inspired
Magazine: Search the archives
#Coffee
A smiling Caucasian couple
#BabyBoomers